Ao Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ao Ma has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Xiaozhi Zhao
Department of Andrology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
2 shared publications Xun Wang
Department of Andrology, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College Nanjing Medical University Nanjing Jiangsu China
2 shared publications- Beibei Zhang
Department of Urology & Andrology Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang China
1 shared publication Bingbing Wu
Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou Guangdong China
1 shared publication- Chao Liu
Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou Guangdong China
1 shared publication - Chong Xie
Department of Urology and Andrology , Sir Run Run Shaw Hospital , Zhejiang University School of Medicine , Hangzhou , Zhejiang , China , zju.edu.cn
1 shared publication
Latest Publications
DNAH14 Variants Are Associated With Asthenozoospermia and Impaired Mitochondria
Background: Male infertility affects approximately 15%–20% of couples worldwide, with asthenozoospermia accounting for about 19% of cases. Nevertheless, the genetic basis of many asthenozoospermia cases remains poorly understood. Objectives: To investigate whether DNAH14 variants cause asthenozoospermia and to explore the underlying mechanisms related to sperm motility and mitochondrial function. Materials and Methods: Whole‐exome sequencing was performed on six Chinese individuals with asthenozoospermia. Dnah14 ‐disrupted male mice were generated to assess fertility phenotypes. Comprehensive kinetics analysis, quantitative proteomics, Gene Ontology (GO) enrichment analysis, transmission electron microscopy, and Seahorse assays were utilized to investigate sperm function, protein alterations, and mitochondrial bioenergetics. Results: Six DNAH14 variants were identified in the affected individuals. Disruption of Dnah14 in male mice led to subfertility characterized by impaired sperm motility and fertilization capacity. Dnah14 ‐deficient spermatozoa exhibited reduced flagellar beat amplitude but increased beat frequency. Quantitative proteomic analysis indicated substantial alterations in sperm protein composition, with GO analysis revealing associations with mitochondrial translation and mitochondrial inner membrane pathways. Transmission electron microscopy showed abnormal mitochondrial morphology, and Seahorse assays detected significantly reduced oxidative phosphorylation and glycolysis. Discussion and Conclusions: DNAH14 is a critical regulator of sperm flagellar beat amplitude and mitochondrial bioenergetics, and variants in DNAH14 might be an important cause of asthenozoospermia.
DNAH14 Variants Are Associated With Asthenozoospermia and Impaired Mitochondria
Background: Male infertility affects approximately 15%–20% of couples worldwide, with asthenozoospermia accounting for about 19% of cases. Nevertheless, the genetic basis of many asthenozoospermia cases remains poorly understood. Objectives: To investigate whether DNAH14 variants cause asthenozoospermia and to explore the underlying mechanisms related to sperm motility and mitochondrial function. Materials and Methods: Whole‐exome sequencing was performed on six Chinese individuals with asthenozoospermia. Dnah14 ‐disrupted male mice were generated to assess fertility phenotypes. Comprehensive kinetics analysis, quantitative proteomics, Gene Ontology (GO) enrichment analysis, transmission electron microscopy, and Seahorse assays were utilized to investigate sperm function, protein alterations, and mitochondrial bioenergetics. Results: Six DNAH14 variants were identified in the affected individuals. Disruption of Dnah14 in male mice led to subfertility characterized by impaired sperm motility and fertilization capacity. Dnah14 ‐deficient spermatozoa exhibited reduced flagellar beat amplitude but increased beat frequency. Quantitative proteomic analysis indicated substantial alterations in sperm protein composition, with GO analysis revealing associations with mitochondrial translation and mitochondrial inner membrane pathways. Transmission electron microscopy showed abnormal mitochondrial morphology, and Seahorse assays detected significantly reduced oxidative phosphorylation and glycolysis. Discussion and Conclusions: DNAH14 is a critical regulator of sperm flagellar beat amplitude and mitochondrial bioenergetics, and variants in DNAH14 might be an important cause of asthenozoospermia.
- 13 September 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (6) , 763-767
A Homozygous Variant in DMRTB1 Is Associated With Non‐Obstructive Azoospermia in Humans
Non‐obstructive azoospermia (NOA) represents the most severe form of male infertility, and the pathogenesis in partial patients can be attributed to endocrine dysfunction or heritable genetic variants. Although the application of whole‐exome sequencing (WES) has facilitated the identification of numerous pathogenic genes associated with NOA, the genetic etiology of a significant proportion of cases remains elusive. In this study, we identified an NOA patient carrying a novel variant in DMRTB1 (c.792–797del, p.265–266del). The variant was rare in public databases and predicted to be likely pathogenic according to the American College of Medical Genetics (ACMG) guidelines. Structural modeling performed by SWISS‐MODEL revealed the localized structural perturbations within residues 254–266, which may induce functional alterations. Histological analysis (H&E staining) of the testicular tissue revealed a complete absence of mature sperm within the seminiferous tubules, which is consistent with the essential role of this gene demonstrated in Dmrt6 knockout mice. Our findings demonstrate that the identified DMRTB1 variant is closely associated with the pathogenesis of NOA, thereby providing valuable genetic evidence for the diagnosis of NOA.
- 13 September 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (6) , 763-767
A Homozygous Variant in DMRTB1 Is Associated With Non‐Obstructive Azoospermia in Humans
Non‐obstructive azoospermia (NOA) represents the most severe form of male infertility, and the pathogenesis in partial patients can be attributed to endocrine dysfunction or heritable genetic variants. Although the application of whole‐exome sequencing (WES) has facilitated the identification of numerous pathogenic genes associated with NOA, the genetic etiology of a significant proportion of cases remains elusive. In this study, we identified an NOA patient carrying a novel variant in DMRTB1 (c.792–797del, p.265–266del). The variant was rare in public databases and predicted to be likely pathogenic according to the American College of Medical Genetics (ACMG) guidelines. Structural modeling performed by SWISS‐MODEL revealed the localized structural perturbations within residues 254–266, which may induce functional alterations. Histological analysis (H&E staining) of the testicular tissue revealed a complete absence of mature sperm within the seminiferous tubules, which is consistent with the essential role of this gene demonstrated in Dmrt6 knockout mice. Our findings demonstrate that the identified DMRTB1 variant is closely associated with the pathogenesis of NOA, thereby providing valuable genetic evidence for the diagnosis of NOA.
- Open Access
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 7629729
Pathogenic Variants in PET Complex Encoding Genes TDRD12 and EXD1 Impair piRNA Biogenesis and Cause Male Infertility
Background: Nonobstructive azoospermia (NOA), the most severe form of male infertility, has approximately 30% of its cases attributed to genetic factors. However, current genetic research only explains a small fraction of NOA cases. Methods: Here, 156 infertile Chinese patients diagnosed with idiopathic male infertility were recruited. Whole exome sequencing and subsequent bioinformatic analysis were performed to find candidate pathogenic variants. Sanger sequencing was used to validate the candidate variants. Quantitative reverse‐transcript PCR (RT‐qPCR) was performed to detect the mRNA expression of TDRD12 and related piRNA genes. Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients′ biopsies. Intracytoplasmic sperm injection (ICSI) was applied for assisted fertilization. Additionally, small RNA sequencing was performed to identify the abnormalities of piRNA biogenesis. Results: We identified eight variants in PET (PIWI‐EXD1‐TDRD12) complex encoding genes TDRD12 and EXD1 from three NOA patients and one oligoasthenozoospermia patient. These variants, which were rare or absent in public human databases, were predicted to be deleterious. Notably, TDRD12 mRNA was absent in three NOA patients. Testicular histopathological analyses revealed that spermatogenesis was arrested at zygotene stage in patients carrying biallelic TDRD12 variants. Further immunofluorescence staining of L1ORF1p and small RNA sequencing revealed disruptions in piRNA biogenesis and subsequent derepression of retrotransposons. Further assisted reproduction outcomes showed that one of the individuals conceived successfully after ICSI. Conclusion: Overall, this study significantly expands the mutational phenotype of PET complex‐encoding genes and significantly advances our understanding of spermatogenic failure and male infertility. Our findings provide direct clinical and functional evidence that the function of the PET complex and piRNA biogenesis is highly conserved between humans and mice.
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 7629729
Open AccessPathogenic Variants in PET Complex Encoding Genes TDRD12 and EXD1 Impair piRNA Biogenesis and Cause Male Infertility
Background: Nonobstructive azoospermia (NOA), the most severe form of male infertility, has approximately 30% of its cases attributed to genetic factors. However, current genetic research only explains a small fraction of NOA cases. Methods: Here, 156 infertile Chinese patients diagnosed with idiopathic male infertility were recruited. Whole exome sequencing and subsequent bioinformatic analysis were performed to find candidate pathogenic variants. Sanger sequencing was used to validate the candidate variants. Quantitative reverse‐transcript PCR (RT‐qPCR) was performed to detect the mRNA expression of TDRD12 and related piRNA genes. Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients′ biopsies. Intracytoplasmic sperm injection (ICSI) was applied for assisted fertilization. Additionally, small RNA sequencing was performed to identify the abnormalities of piRNA biogenesis. Results: We identified eight variants in PET (PIWI‐EXD1‐TDRD12) complex encoding genes TDRD12 and EXD1 from three NOA patients and one oligoasthenozoospermia patient. These variants, which were rare or absent in public human databases, were predicted to be deleterious. Notably, TDRD12 mRNA was absent in three NOA patients. Testicular histopathological analyses revealed that spermatogenesis was arrested at zygotene stage in patients carrying biallelic TDRD12 variants. Further immunofluorescence staining of L1ORF1p and small RNA sequencing revealed disruptions in piRNA biogenesis and subsequent derepression of retrotransposons. Further assisted reproduction outcomes showed that one of the individuals conceived successfully after ICSI. Conclusion: Overall, this study significantly expands the mutational phenotype of PET complex‐encoding genes and significantly advances our understanding of spermatogenic failure and male infertility. Our findings provide direct clinical and functional evidence that the function of the PET complex and piRNA biogenesis is highly conserved between humans and mice.